Net income · 2011–2025
Teva Pharmaceutical Industries net income
$1.4B+$3.0B · FY2025
Teva Pharmaceutical Industries (TEVA) reported $1.4B in net income for fiscal 2025, +$3.0B from the year before.
| Fiscal year | Net income | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.4B | +$3.0B | Open → |
| FY20242024-12-31 | −$1.6B | −$1.1B | Open → |
| FY20232023-12-31 | −$559M | +$1.9B | Open → |
| FY20222022-12-31 | −$2.4B | −$2.9B | Open → |
| FY20212021-12-31 | $417M | +$4.4B | Open → |
| FY20202020-12-31 | −$4.0B | −$3.0B | Open → |
| FY20192019-12-31 | −$999M | +$1.2B | Open → |
| FY20182018-12-31 | −$2.2B | +$14.1B | Open → |
| FY20172017-12-31 | −$16.3B | −$16.6B | Open → |
| FY20162016-12-31 | $329M | −79.3% | Open → |
| FY20152015-12-31 | $1.6B | −48.0% | Open → |
| FY20142014-12-31 | $3.1B | +140.7% | Open → |
| FY20132013-12-31 | $1.3B | −35.4% | Open → |
| FY20122012-12-31 | $2.0B | −28.9% | Open → |
| FY20112011-12-31 | $2.8B | — | Open → |
Net income — Net income is profit after tax and all expenses, as reported in the annual filing. Companies reporting a loss are excluded from this ranking.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −4.7%
Net income at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Teva Pharmaceutical Industries net income |url=https://companiesranked.com/en/company/teva-pharmaceutical-industries/net-income |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Teva Pharmaceutical Industries net income. CompaniesRanked. https://companiesranked.com/en/company/teva-pharmaceutical-industries/net-incomeBibTeX
@misc{companiesranked-en-company-teva-pharmaceutical-industries-net-income-2026,
author = {{CompaniesRanked}},
title = {{Teva Pharmaceutical Industries net income}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/teva-pharmaceutical-industries/net-income}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-034532 · February 3, 2026
{{cite web |title=Teva Pharmaceutical Industries net income — 10-K (0001193125-26-034532) |url=https://www.sec.gov/Archives/edgar/data/818686/000119312526034532/d93612d10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-03}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.